A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.
Cystic Fibrosis
COVID-19 Vaccine | Community COVID-19 Testing | COVID-19 Updates | Visiting a Patient – Severe Risk Status
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.